Non-Individualized Cancer Vaccines May Have Limited Applicability

Feb 24, 2017

|

NEW YORK (GenomeWeb) – Based on information in tens of thousands of tumor genomes, a research team from Foundation Medicine and Roche Pharma Research & Early Development concluded that it would be unlikely to come up with a cancer vaccine that would benefit more than a fraction of the population.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

More Common Than Thought

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

Even for Prizes, Women Get Less Money

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

This Week in Nature

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Scramble to Keep the Work Alive

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.

Featured White Papers

KAPA HyperPrep Kits offer a flexible, high-efficiency library preparation solution for PCR-free human whole-genome sequencing

Controlling Ribonuclease (RNase) with High Irradiance UV LED Light Engines

DNA Quantification and Normalization with Promega QuantiFluor Dyes on the Fluent Laboratory Automation Solution

Nucleic Acid Quantification and Normalization by UV Measurement on the Fluent Laboratory Automation Solution

Jan

30

Featured Webinar

A Long-Read vs. Short-Read Platform Comparison: Best NGS Approaches for Microbiome Studies

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.

Jan

31

Featured Webinar

Leveraging Single-Cell Genomics to Identify Drivers of Enhanced Immunity

This webinar highlights the use of single-cell genomics to identify distinct cell types and states associated with enhanced immunity.

Feb

14

Featured Webinar

Transcriptome of an Agricultural Pest Delineated by Oxford Nanopore RNA-Seq

This webinar will describe a project that applied Oxford Nanopore long-read RNA-seq to explore the transcriptional landscape of a damaging agricultural pest.

Feb

19

Featured Webinar

Rapid Testing of Solid Tumor Samples Using a Single-Vial NGS Assay

This webinar will demonstrate how clinical laboratories can develop their own customized targeted next-generation sequencing (NGS)-based solid tumor panels.

Main menu